SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results" ALT"SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results"May 12, 2017By Alex Keown</A...…

Continue ReadingSoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results

Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-glaxosmithkline.jpg" NAME"Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options" ALT"Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options"May…

Continue ReadingTop GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options